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Abstract
Infertility poses a large burden to the healthcare system and despite 
advancements in assisted reproductive technologies (ART), there 
continues to be sub-optimal outcomes. Given its anti-oxidative 
properties, melatonin has been suggested as an adjuvant therapy to 
improve in-vitro fertilization (IVF) outcomes. A comparative analysis of 
the literature demonstrated positive correlation between melatonin 
supplementation and oocyte and embryo quality among women
undergoing IVF. However, further research is needed, as current 
literature is unable to demonstrate correlation to clinical pregnancy 
rates. 
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● Based on data from the National Survey of Family Growth (NSFG), it 
is estimated that about 10% of reproductive-aged females in the US 
are affected by infertility.1
● IVF has an average cost per cycle ranging from $10,000- $15,000.2
● Associated negative outcomes of IFV include: unsuccessful cycles, 
multiple births, low birth weight infants and preterm births.2
● Given the cost and risks of treatment, it is imperative to explore new 
primary and adjuvant therapies that are potentially safe, effective, 
and reasonably accessible to help improve outcomes.
● Melatonin has been shown to be able to reduce damaging reactive 
oxygen species (ROS) within ovarian follicles.3
● This study seeks to explore the effect of melatonin during IVF on 
parameters of oocyte quality, as well as the impact on clinical 
fertilization and pregnancy rates.
Introduction
Methods
• A literature search was conducted using PubMed, Clinical Key, Google 
Scholar and EBSCO. Seven articles were selected based on quality and 
relevance related to the research question, outcomes measured, and 
inclusion and exclusion criteria. 
• Outcomes measured included: number of mature oocytes, fertilization 
rate, embryo quality, and pregnancy rate.
• Results show a positive correlation between melatonin 
supplementation and oocyte and embryo quality during IVF, regardless 
of melatonin dose. 
• However, measures varied slightly between studies, and clinical 
usefulness in regards to fertilization and pregnancy rates were unable 
to be determined. 
• Studies were limited by sample size, which reduced the power of 
results obtained. 
Discussion 
Table 1. Example Table  
Results 
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Investigating the Clinical Usefulness of Melatonin to Improve Infertility 
Treatment Outcomes
Melatonin has been regarded for its anti-oxidative properties, low cost, 
and relative safety. Emerging research on melatonin demonstrates 
antioxidant properties in intra-follicular fluid, suggesting potential 
usefulness in improving fertility outcomes be reducing oxidative stress in 
intra-follicular fluid. The present literature analysis demonstrated 
promising results regarding supplemental melatonin use and improved 
oocyte and embryo quality during IVF. However, the selected studies 
were unable to demonstrate improvements in clinical pregnancy rates. 
Further research is needed before justifying the clinical utility of 
melatonin in IVF therapy.
Conclusion
Table 1. Comparison of Results
Five of the selected studies found significant improvement in 
oocyte and embryo quality with supplementary melatonin 
use when compared to traditional IVF protocol. There was no 
statistical difference between melatonin dose used (1, 3, or 6 
mg). However, only three studies found statistically 
significant improvements in fertilization rate, and none were 
able to demonstrate significant improvement in clinical 
pregnancy rates with melatonin use. 









Batioglu et al. 
(2012)
S NS S NS
Eryilmaz et al. 
(2011)
S NS S NS
Espino et al. 
(2019)
S S S NS
Jahromi et al. 
(2017)
S NS S NS
Nishihara et al. 
(2014)
NS S S N/A
Takasaki et al. 
(2003)
S* NS N/A N/A 
Tamura et al. 
(2008)
N/A S N/A N/A
# Mature oocytes Fertilization Rate Embryo Quality Clinical 
Pregnancy Rate




control group (p <
0.05)








control (p < 0.05)
NS= no difference 
in # of fertilized 
embryos between 
groups (p > 0.05)





compared to no 
melatonin (p <
0.05)
NS= no difference 
in # of Grade 
I/high grade 
embryos between 
groups (p > 0.05)
S= Rate of 
pregnancy was 
higher in the 
treatment group 
compared to the 
control (p < 0.05)
NS= no difference 
in pregnancy rates 
between groups
S= statistically significant results
NS= statistically non-significant results
* = significant difference between 3 mg treatment group and control group
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